SCHEMBL6663821

SCHEMBL6663821

O=c1[nH]c(=O)n(-c2ccccc2)c2nc[nH]c12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNP P00491 1/20 0.61
MAPK1 P28482 1/20 0.57
PDE4A P27815 7/20 0.52
PDE4B Q07343 7/20 0.52
PDE4C Q08493 7/20 0.52
PDE4D Q08499 7/20 0.52
KMT2A Q03164 2/20 0.52
ADORA2A P29274 3/20 0.51
HPGD P15428 2/20 0.49
HSD17B10 Q99714 2/20 0.49
ALDH1A1 P00352 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
ADORA2B P29275 1/20 0.49
ADORA1 P30542 1/20 0.49
BLM P54132 1/20 0.49
PDE3A Q14432 1/20 0.49
POLB P06746 1/20 0.44
SRC P12931 1/20 0.43
GAA P10253 2/20 0.43
GSK3A P49840 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9031500 0.85 MAPK1 (0.55) PNPMAPK1PDE4APDE4BPDE4C
SCHEMBL31241336 0.78 PDE4A (0.43) PNPMAPK1PDE4APDE4BPDE4C
SCHEMBL9835368 0.76 MAPK1 (0.76) MAPK1PDE4APDE4BPDE4CPDE4D
SCHEMBL9032111 0.76 PNP (1.00) PNPPDE4APDE4BPDE4CPDE4D
SCHEMBL378878 0.75 ADORA2B (0.58) MAPK1PDE4APDE4BPDE4CPDE4D
SCHEMBL16474819 0.75 PDE4A (0.44) PNPMAPK1PDE4APDE4BPDE4C
SCHEMBL6662593 0.75 PNP (0.57) PNPMAPK1PDE4APDE4BPDE4C
SCHEMBL3554510 0.74 CSNK2A1 (0.43) MAPK1KMT2AADORA2AHSD17B10ALDH1A1
SCHEMBL22560005 0.74 CSNK2A1 (0.54) PNPKMT2AHSD17B10
SCHEMBL9584926 0.73 MAPK1 (1.00) MAPK1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1257552-B1 XANTHINE DERIVATIVES, INTERMEDIATES AND USE FOR TREATING OSTEOPOROSIS AVENTIS PHARMA SA (FR) 2004-08-18 EP disclosed
EP-1257552-A1 XANTHINE DERIVATIVES, INTERMEDIATES AND USE FOR TREATING OSTEOPOROSIS Aventis Pharma S.A. (FR) 2002-11-20 EP disclosed
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 EP disclosed
EP-0771813-B1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines HOECHST AG (DE) 2002-01-16 EP disclosed
WO-2001060824-A1 XANTHINE DERIVATIVES, INTERMEDIATES AND USE FOR TREATING OSTEOPOROSIS AVENTIS PHARMA S.A. (FR) 2001-08-23 WO disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 US disclosed
US-5728686-A TREATMENT OF MUSCULAR DYSTROPHY HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-17 US disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed
EP-0771813-A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-07 EP disclosed
EP-0417790-B1 S-triazolo[3,4-i]purine derivatives KYOWA HAKKO KOGYO KK (JP) 1996-12-04 EP disclosed
EP-0319854-B1 Process for the methylation of xanthins BOEHRINGER INGELHEIM KG (DE) 1994-03-02 EP disclosed
US-5173492-A Bronchodilator agents KYOWA HAKKO KOGYO CO., LTD. (JP) 1992-12-22 US disclosed
EP-0417790-A2 S-triazolo[3,4-i]purine derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 1991-03-20 EP disclosed
EP-0319854-A2 Process for the methylation of xanthins BOEHRINGER INGELHEIM KG (DE) 1989-06-14 EP disclosed